Chiquita Brooks-LaSure, Centers for Medicare and Medicaid Services administrator (AP Photo/Evan Vucci)

June 1, 2023 02:05 PM EDTUpdated 03:00 PM

CMS makes it official: Coverage for new Alzheimer's drugs once full approvals arrive

Zachary Brennan

Senior Editor

As Congressional and advocacy group pressure has been heated, the Centers for Medicare and Medicaid Services reaffirmed today that if amyloid-targeted drugs to slow the …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

CMS makes it official: Coverage for new Alzheimer's drugs once full approvals arrive

Zachary Brennan

Senior Editor

Sign up to read this article for free.

Global Head of Marketing

Bachem

Bubendorf, BL, Switzerland

Former FDA chief calls job cuts ‘haphazard, poorly thought-out’

NIH payment cuts are 'reasoned and rational,' government says

Novo looks to recoup $830M from hypertension drug partner, claiming fraud

After research pivot, Biogen beefs up pipeline with Stoke's late-stage Dravet candidate

As part of turnaround, Solid Bio reports promising initial data for Duchenne gene therapy

Trusted protection: Why the current meningococcal vaccination schedule shouldn’t change without strong evidence

CMS makes it of­fi­cial: Cov­er­age for new Alzheimer's drugs once full ap­provals ar­rive

Senior Editor

Sign up to read this article for free.

Bachem

Bubendorf, BL, Switzerland

CMS makes it official: Coverage for new Alzheimer's drugs once full approvals arrive